fa بررسی شیوع افسردگی در بیماران مبتلابه رتینوپاتی دیابتی روانشناسي باليني Clinical Psychology پژوهشي Original <span style="font-family:Tahoma;"><strong><span style="position:relative;top:-1.0pt;letter-spacing:-.15pt;"><span style="color:#274cc3;"><span style="font-size:10.0pt;">سابقه و هدف:</span></span></span></strong>&nbsp;<span style="color:windowtext;"><span style="font-size:10.0pt;">رتینوپاتی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">دیابتی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">یکی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">از</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">عوارض</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">مهم</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">و</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">ناتوان‌کننده</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">دیابت</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">است</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">که</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">شیوع</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">آن</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">در</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">بیشتر</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">کشورها</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">رو</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">به</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">افزایش</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">است</span></span><span style="color:windowtext;"><span style="font-size:10.0pt;">. </span></span><span style="color:windowtext;"><span style="font-size:10.0pt;">رتینوپاتی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">دیابتی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">تأثیر</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">شگرفی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">بر</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">کیفیت</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">زندگی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">فرد</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">دارد</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">و</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">باعث</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">افزایش</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">علائم</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">اضطراب</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">و</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">افسردگی</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">در</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">افراد</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">مبتلابه</span></span> <span style="color:windowtext;"><span style="font-size:10.0pt;">دیابت</span></span><span style="color:windowtext;"><span style="font-size:10.0pt;"> می‌</span></span><span style="color:windowtext;"><span style="font-size:10.0pt;">شود</span></span><span style="color:windowtext;"><span style="font-size:10.0pt;">. به همین منظور، این مطالعه با هدف تعیین</span></span><span style="color:windowtext;"><span style="font-size:10.0pt;"> شیوع افسردگی در بیماران مبتلابه رتینوپاتی دیابتی انجام شد.</span></span></span> <pre dir="RTL" style="text-align:justify;direction:rtl;unicode-bidi:embed;"> <span style="font-family:Tahoma;"><strong><span style="position:relative;top:-1.0pt;letter-spacing:.1pt;"><span style="color:#274cc3;">مواد و روش‌‌ها:</span></span></strong>&nbsp;در این مطالعه توصیفی-مقطعی به روش نمونه‌گیری در دسترس و متوالی 245 بیمار مبتلابه رتینوپاتی مراجعه‌کننده به کلینیک چشم بیمارستان فرشچیان همدان طی سال‌های 1398-1399 انتخاب و از نظر ابتلا به افسردگی با پرسش‌نامه 21 سؤالی بک ارزیابی شدند. داده‌ها با نرم‌افزار <span dir="LTR"><span style="font-size:9.0pt;">SPSS</span></span> نسخه 16 در سطح اطمینان 95 درصد تحلیل شدند.</span><span style="letter-spacing:.1pt;"><span style="font-family:B Nazanin;"></span></span></pre> <pre dir="RTL" style="text-align:justify;direction:rtl;unicode-bidi:embed;"> </pre> <pre dir="RTL" style="text-align:justify;direction:rtl;unicode-bidi:embed;"> <span style="font-family:Tahoma;"><strong><span style="position:relative;top:-1.0pt;letter-spacing:.1pt;"><span style="color:#274cc3;">یافته‌ها:</span></span></strong>&nbsp;میانگین سن بیماران 5/8<span style="font-size:9.0pt;">&plusmn;</span>47/54 سال، میانگین مدت ابتلا به دیابت 15/4<span style="font-size:9.0pt;">&plusmn;</span>5/8 سال و از نظر جنسیت 3/41 درصد مرد و 7/58 درصد زن بودند. شیوع افسردگی در بیماران مبتلابه رتینوپاتی دیابتی در کل 8/49 درصد و در رتینوپاتی پرولیفراتیو و غیرپرولیفراتیو به ترتیب 2/68 و 43 درصد بود (001/0<span dir="LTR"><span style="font-size:9.0pt;">P<</span></span>). در مردان و زنان 9/45 و 5/51 درصد (428/0<span dir="LTR"><span style="font-size:9.0pt;">P=</span></span>) و بیماران تحت درمان با انسولین و بدون انسولین 4/50 و 2/49 درصد (846/0<span dir="LTR"><span style="font-size:9.0pt;">P=</span></span>) بود. ضریب همبستگی بین اختلال افسردگی با سن 123/0 (054/0<span dir="LTR"><span style="font-size:9.0pt;">P=</span></span>) و با مدت ابتلا به دیابت 369/0 (001/0<span dir="LTR"><span style="font-size:9.0pt;">P<</span></span>) بود.<span style="letter-spacing:.1pt;"></span></span></pre> <span style="font-family:Tahoma;"><strong><span style="position:relative;top:-1.0pt;letter-spacing:.1pt;"><span style="color:#274cc3;"><span style="font-size:10.0pt;">نتیجه‌گیری:</span></span></span></strong>&nbsp;<span style="color:windowtext;"><span style="font-size:10.0pt;">افسردگی یکی از مشکلات شایع بیماران مبتلابه رتینوپاتی دیابتی است و بین شدت رتینوپاتی و مدت ابتلا به دیابت با شیوع افسردگی ارتباط معنی‌داری وجود دارد.</span></span></span><span style="letter-spacing:.1pt;"><span style="color:windowtext;"><span style="font-family:B Nazanin;"><span style="font-size:10.0pt;"></span></span></span></span> <div style="text-align: justify;"><span style="font-size:12px;"><span style="font-family:Tahoma;"><strong>Background and Objective:</strong>Diabetic retinopathy is one of the most important and debilitating complications of diabetes with an increasing prevalence in most countries. It has a dramatic effect on people&#39;s quality of life and increases the symptoms of anxiety and depression in patients with diabetes. Therefore, the present study aimed to determine the prevalence of depression in patients with diabetic retinopathy.<br> <strong>Materials and Methods:</strong>This descriptive/ cross-sectional study was conducted on 245 patients with retinopathy referred to the ophthalmology clinic of Farshchian Hospital in Hamadan during 2019- 2020. They were selected via available and consecutive sampling method and were evaluated for depression with the 21-item Beck questionnaire. Data were analyzed in SPSS software (version 16) at a 95% confidence level.<br> <strong>Results:</strong>The mean scores of patients&#39; age and duration of diabetes were reported as 54.47&plusmn; 8.5 and 8.5 &plusmn; 4.15 years, respectively. In terms of gender, the majority of participants (58.7%) were female. The prevalence of depression in patients with diabetic retinopathy was obtained at 49.8% and in proliferative and non-proliferative retinopathy were 68.2% and 43%, respectively (P<0.001). The prevalence rates of depression in men and women were reported as 45.9% and 51.5% (P=0.428). Moreover, in patients treated with insulin and without insulin, the prevalence rates of depression were obtained at 50.4% and 49.2% (P=0.846). The correlation coefficients of depressive disorder with age and duration of diabetes were calculated at 0.123 (P=0.054) and 0.369 (P<0.001), respectively.<strong><span dir="RTL"></span></strong><br> <strong>Conclusion:</strong>Depression is one of the most serious problems in patients with diabetic retinopathy. As evidenced by the results of the present study, the prevalence ofdepression is significantly correlated with the severity of retinopathy and duration of diabetes.</span></span></div> افسردگی, دیابت شیرین, رتینوپاتی Depression, Diabetes Mellitus, Retinopathy 226 231 http://sjh.umsha.ac.ir/browse.php?a_code=A-12-82-6&slc_lang=fa&sid=1 Nooshin Bazzazi نوشین بزازی 100319475328460014152 100319475328460014152 No Associate Professor, Department of Ophthalmology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran Mona Sharafi Zamir مونا شرفی ضمیر 100319475328460014153 100319475328460014153 No General Practitioner, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran Siamak Akbarzadeh سیامک اکبرزاده 100319475328460014154 100319475328460014154 No Associate Professor, Department of Ophthalmology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran Younes Mohammadi یونس محمدی 100319475328460014155 100319475328460014155 No Associate Professor, Department of Epidemiology, School of Health, Hamadan University of Medical Sciences, Hamadan, Iran Mohammad Ahmadpanah محمد احمدپناه m1ahmad2000@gmail.com 100319475328460014156 100319475328460014156 Yes Associate Professor, Department of Ophthalmology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran